The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics

被引：255

作者：

Cruz, Pedro M. R. ^{[1
]}

Mo, Huanbiao ^{[2
]}

McConathy, Walter J. ^{[3
]}

Sabnis, Nirupama ^{[1
]}

Lacko, Andras G. ^{[1
]}

机构：

[1] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA

[2] Texas Womans Univ, Dept Nutr & Food Sci, Denton, TX 76204 USA

[3] LipoMed Ltd Co, Ft Worth, TX USA

来源：

FRONTIERS IN PHARMACOLOGY | 2013年 / 4卷

关键词：

cholesterol metabolism; lipoprotein transport; carcinogenesis; drug delivery system; SR-B1; receptor; LOW-DENSITY-LIPOPROTEIN; CELLS IN-VIVO; LIPID RAFTS; MEVALONATE PATHWAY; REDUCTASE-ACTIVITY; DELIVERY VEHICLES; RECEPTOR-ACTIVITY; LEUKEMIC-CELLS; DRUG-DELIVERY; GROWTH;

D O I：

10.3389/fphar.2013.00119

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

While the unique metabolic activities of malignant tissues as potential targets for cancer therapeutics has been the subject of several recent reviews, the role of cholesterol metabolism in this context is yet to be fully explored. Cholesterol is an essential component of mammalian cell membranes as well as a precursor of bile acids and steroid hormones. The hypothesis that cancer cells need excess cholesterol and intermediates of the cholesterol biosynthesis pathway to maintain a high level of proliferation is well accepted, however the mechanisms by which malignant cells and tissues reprogram cholesterol synthesis, uptake and efflux are yet to be fully elucidated as potential therapeutic targets. High and low density plasma lipoproteins are the likely major suppliers of cholesterol to cancer cells and tumors, potentially via receptor mediated mechanisms. This review is primarily focused on the role(s) of lipoproteins in carcinogenesis, and their future roles as drug delivery vehicles for targeted cancer chemotherapy.

引用

页数：7

共 83 条

[11] Chen H W, 1978, Prog Exp Tumor Res, V22, P275
[12] Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor
Chen, X
Resh, MD
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) : 49631 - 49637
[13] Targeting tumor cell metabolism with statins
Clendening, J. W.
Penn, L. Z.
[J]. ONCOGENE, 2012, 31 (48) : 4967 - 4978
[14] Dysregulation of the mevalonate pathway promotes transformation
Clendening, James W.
Pandyra, Aleks
Boutros, Paul C.
El Ghamrasni, Samah
Khosravi, Fereshteh
Trentin, Grace A.
Martirosyan, Anna
Hakem, Anne
Hakem, Razqallah
Jurisica, Igor
Penn, Linda Z.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (34) : 15051 - 15056
[15] LIPOPROTEINS AS POTENTIAL SITE-SPECIFIC DELIVERY SYSTEMS FOR DIAGNOSTIC AND THERAPEUTIC AGENTS
COUNSELL, RE
POHLAND, RC
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) : 1115 - 1120
[16] Cholesterol and breast cancer development
Danilo, Christiane
Frank, Philippe G.
[J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) : 677 - 682
[17] The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
DeBerardinis, Ralph J.
Lum, Julian J.
Hatzivassiliou, Georgia
Thompson, Craig B.
[J]. CELL METABOLISM, 2008, 7 (01) : 11 - 20
[18] Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol
Dillard, Paulette R.
Lin, Ming-Fong
Khan, Shafiq A.
[J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 295 (1-2) : 115 - 120
[19] Oxysterol receptors, AKT and prostate cancer
Dufour, Julie
Viennois, Emilie
De Boussac, Hugues
Baron, Silvere
Lobaccaro, Jean-Marc
[J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) : 724 - 728
[20] Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity
Duncan, RE
El-Sohemy, A
Archer, MC
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33079 - 33084

← 1 2 3 4 5 6 7 8 9 →